Kari Henrik Johannes Ehinger

Title: Kari Henrik Johannes Ehinger: Innovator in Mitochondrial Function Enhancement

Introduction

Kari Henrik Johannes Ehinger is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biochemistry, particularly in enhancing mitochondrial ATP production. His innovative work has led to the development of unique compounds that have potential applications in improving cellular energy metabolism.

Latest Patents

Ehinger holds a patent for "Protected succinates for enhancing mitochondrial ATP-production." This patent discloses mono or di-succinate compounds where one or both of the acid groups in the succinate core are protected in the form of biologically labile moieties. The compounds are designed to enhance mitochondrial function, which is crucial for energy production in cells. The specific formula of these compounds allows for a versatile application in various biological contexts.

Career Highlights

Kari Ehinger is associated with Neurovive Pharmaceuticals AB, a company focused on developing innovative treatments for mitochondrial diseases. His work at Neurovive has positioned him as a key figure in the research and development of therapies aimed at improving mitochondrial health and function.

Collaborations

Ehinger has collaborated with notable colleagues such as Hans Georg Fliri and Rhonan Lee Ford. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field of mitochondrial function.

Conclusion

Kari Henrik Johannes Ehinger is a distinguished inventor whose work in enhancing mitochondrial ATP production has the potential to impact various therapeutic areas. His innovative compounds and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.